Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages including the XFG and NB.1.8.1 variants1 compared to 2024-20 ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages - including the XFG and NB.1.8.1 variants1 - compared to ...

Many people have recently questioned the relevance of the COVID vaccine. However new study shows that it has a positive ...

A recent study revealed that cancer patients are at a significantly higher risk of contracting a severe COVID infection, but ...

COVID boosters reduced cancer patients’ hospitalizations and ICU stays by 29%, researchers report in JAMA Oncology. Overall, ...